Micro Guide Catheters Market is Growing at an Extensive CAGR of 8% During Forecast to 2023


Market Overview:
Catheters are used in the treatment of diseases like Cardiovascular, Neurovascular, Urology and many more.  A catheter is inserted into the body for the administration of liquid medication or gas during the treatment of diseases.
Additional factors substantiating the market growth include growing prevalence of cardiovascular and urological diseases fuelled by the heady or sedentary lifestyle, reasoning the augmented demand for the product.
The Micro Guide Catheters Market is growing pervasively; mainly due to the rapid technological advancements. According to a recent study report published by the Market Research Future (MRFR), the booming global Micro Guide Catheters market is expected to gain prominence over the forecast period.  The Market is forecasted to demonstrate a colossal growth by 2027, with a staggering CAGR of 8 % between 2017 and 2023, surpassing its previous growth records in terms of value.   
The traction for micro guide catheters is gaining momentum currently as procedures that involve the use of minimally invasive device. The market is boosted by the growing incidence of cardiovascular and urological diseases globally. The market for micro guide catheters is expected to expand substantially as the catheters guarantee a great deal of safety and efficiency in the high-risk procedures. The reduced recovery time ensured by micro guide catheters is expected to further impel the development of the market in the forecast period.
Key Players:
·         Terumo Europe N.V.
·         LuMend Corporation
·         Covidien AG
·         Boston Scientific Corporation
·         Asahi Intecc Company Limited
·         Volcano Corporation
·         Merit Medical Systems Inc
·         Micro Therapeutics Inc
·         ACIST Medical Systems
·         BrosMed Medical
·         Baylis Medical Medtronic
·         Cordis Corporation
Micro Guide Catheters Market   - Competitive Analysis
The global market for micro guide catheters appears to be fiercely competitive with several well-established and small players operating in the market. These players incorporate collaboration, acquisition, expansion, strategic partnership, & technology launch. Substantial investments are transpired in clinical trials and development. These key players compete based upon pricing and reputation. 
The Market demonstrates high growth potential which is likely to attract several new entrants to the market, resulting in intensified competition. Key players invest heavily in R&D activities and clinical trials to develop effective Micro Guide Catheters. These players are holding the largest market share while other small and medium-sized companies are also growing. Manufacturers strive to develop Micro Guide Catheters with advent technology and unrivaled design and features. 
Micro Guide Catheters Market   - Segments
·         The micro guide catheters market is segmented on the basis of types, application, end-user, and region.
·         On the basis of types, the market is segmented into over the wire micro guide catheters, and flow-directed micro guide catheters.
·         The segmentation on the basis of application consist of neurovascular, cardiovascular, urology and other.
·         On the basis of end user, the micro guide catheters market consists of clinics, hospital, among others.
·         The regions covered in the market are Asia Pacific, Europe, North America, and the Middle East and Africa.
Micro Guide Catheters Market   - Geographical Analysis 
The regions included in the micro guide catheter market globally are Europe, North America, Asia Pacific, and the Middle East and Africa. Owing to the high volume of medical procedures conducted through catheterization in the North American region has made the region a leader in the micro guide catheter globally. The accessibility to infrastructure and technology has provided a significant boost for the expansion of this market in the European and North American region.


Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more